Latest Headlines

  1. INTEGRA Launches New Eco-Friendly ACT Ecolabel Certified AUTO Rack GRIPTIPS® For Benchtop Systems 10/2/2026

    INTEGRA Biosciences has launched the My Green Lab® ACT® Ecolabel certified AUTO rack GRIPTIPS® pipette tips for its benchtop liquid handling platforms.

  2. Andelyn Biosciences To Implement Curator® Platform To Develop And Manufacture Gene Therapy AAV9-GM2 For Queen's University To Treat GM2 Gangliosidoses 9/21/2026

    Andelyn Biosciences, Inc., a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy candidate for the treatment of GM2 gangliosidoses, such as Tay-Sachs and Sandhoff diseases.

  3. Andelyn Biosciences And Its Curator® Platform Achieve First FDA-Approved Commercial Gene Therapy Manufacturing Milestone Following The FDA's Approval Of Ultragenyx's Fayuvi™ For The Treatment Of Sanfilippo Syndrome Type A (MPS IIIA) 9/21/2026

    Andelyn Biosciences (“Andelyn”), a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (“CDMO”), today announced that it is now manufacturing Fayuvi™ (rebisufligene etisparvovec-hopf), an FDA-approved gene therapy, for commercial supply at its Columbus, Ohio facility. 

  4. Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop To Improve Efficiency And Consistency In Gene Therapy Manufacturing 9/18/2026
  5. Emulate Enters Final Stage Of FDA ISTAND Program For Human Liver-Chip With Submission Of Qualification Package Covering Both Zoë® And AVA™ Organ-Chip Platforms 9/18/2026

    Emulate, Inc., the leading provider of next-generation Organ-on-a-Chip technology, today announced it has submitted its FDA Innovative Science and Technology Approaches for New Drugs (ISTAND) full qualification package (FQP) for its Human Liver-Chip, advancing the company’s efforts to establish Organ-on-a-Chip technology as a qualified Drug Development Tool (DDT) for drug-induced liver injury (DILI) assessment.

  6. Advancing Pharmaceutical Manufacturing With Esco Lifesciences At ISPE 2026 9/17/2026
  7. 3PBIOVIAN Appoints Ponchi Kantt-Neaz As Global Executive Business Director, Marking A Milestone In Its oCommercial Strategy 9/16/2026

    3PBIOVIAN has appointed Ponchi Kantt-Neaz as Global Executive Business Director, marking an important milestone in the company’s global commercial strategy and further strengthening its commercial leadership as the company continues to expand its presence in the global CDMO market.

  8. Andelyn Biosciences To Scale Manufacturing For Genprex's Diabetes Gene Therapy Program 9/1/2026
  9. AST Names Industry Veteran Jon Lenihan As Chief Commercial Officer 8/31/2026
  10. AES Cleanroom Technology Panels Earn FM 4882 Approval, Addressing The Cleanroom Risk That Fire Ratings Miss 8/27/2026